 Federal health officials are taking steps to ensure that vaccines and tests are ready if bird flu starts spreading among humans. The Centers for Disease Control and Prevention says the risk to the general public remains low, as NPR's Will Stone reports. COVID vaccine maker Moderna is receiving about $176 million from the federal government to develop an mRNA-based influenza vaccine that could be deployed against bird flu.